Response to ustekinumab in three pediatric patients with alopecia areata-Reference-Cited by-同舟云学术

Response to ustekinumab in three pediatric patients with alopecia areata

Published:2018-10-18 Issue:1 Volume:36 Page:
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Aleisa Abdullah¹^ORCID,Lim Yeun²,Gordon Samantha¹^ORCID,Her Min Ji¹,Zancanaro Pedro¹,Abudu Minawaer¹,Deverapalli Sandhya Chowdary¹,Madani Abdulaziz¹,Rosmarin David¹

Affiliation:

1. Department of Dermatology Tufts Medical Center Boston Massachusetts

2. Tufts School of Medicine Tufts University Boston Massachusetts

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.13699

Reference4 articles.

1. Alopecia Areata

2. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata

3. Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study

4. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective;Journal of Pharmacology and Pharmacotherapeutics;2024-05-08

2. Treatment Options for Alopecia Areata in Children and Adolescents;Pediatric Drugs;2024-03-11

3. Alopecia areata;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata;Biomolecules;2023-08-23

5. Alopecia Areata: Current Treatments and New Directions;American Journal of Clinical Dermatology;2023-08-22